Background Document on the AZD1222 Vaccine Against COVID-19 Developed by Oxford University and AstraZeneca

This document highlights WHO’s Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID19 developed by Oxford University and AstraZeneca.